Generation Bio Co. (GBIO)
NASDAQ: GBIO · Real-Time Price · USD
6.17
+0.34 (5.83%)
At close: Sep 9, 2025, 4:00 PM
6.15
-0.02 (-0.32%)
After-hours: Sep 9, 2025, 4:10 PM EDT
Generation Bio Co. Market Cap
Generation Bio Co. has a market cap or net worth of $41.56 million as of September 9, 2025. Its market cap has decreased by -75.29% in one year.
Market Cap
41.56M
Enterprise Value
-16.77M
1-Year Change
-75.29%
Ranking
Category
Stock Price
$6.17
Market Cap Chart
Since June 12, 2020, Generation Bio Co.'s market cap has decreased from $1.07B to $41.56M, a decrease of -96.12%. That is a compound annual growth rate of -46.17%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Sep 9, 2025 | 41.42M | -41.49% |
| Dec 31, 2024 | 70.80M | -35.06% |
| Dec 29, 2023 | 109.03M | -53.31% |
| Dec 30, 2022 | 233.53M | -41.89% |
| Dec 31, 2021 | 401.89M | -68.88% |
| Dec 31, 2020 | 1.29B | 20.54% |
| Jun 12, 2020 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 652.84B |
| Johnson & Johnson | 429.72B |
| AbbVie | 375.50B |
| UnitedHealth Group | 285.64B |
| AstraZeneca | 253.68B |
| Novartis AG | 252.55B |
| Novo Nordisk | 244.67B |
| Abbott Laboratories | 231.38B |